ArticleOncotarget2017

Circulating plasma microRNAs as potential markers to identify EGFR mutation status and to monitor epidermal growth factor receptor-tyrosine kinase inhibitor treatment in patients with advanced non-small cell lung cancer.

Lili Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.